Neoadjuvant Immunotherapy May Facilitate Surgery and Improve Outcomes for Patients With High-Risk Liver Cancer
August 16, 2024
August 16, 2024
PHILADELPHIA, Pennsylvania, Aug. 16 (TNSres) -- The American Association for Cancer Research issued the following news release:
* * *
Patients who would not have otherwise been candidates for surgery achieved successful resection
* * *
Patients with liver cancer who received immune checkpoint inhibitors (ICIs) before surgery--including those who would not have been eligible for surgery by conventional criteria--had similar outcomes to patients . . .
* * *
Patients who would not have otherwise been candidates for surgery achieved successful resection
* * *
Patients with liver cancer who received immune checkpoint inhibitors (ICIs) before surgery--including those who would not have been eligible for surgery by conventional criteria--had similar outcomes to patients . . .